MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 06.11.2025
EyePoint Pharmaceuticals Kurshistorie 2011-2025 | EYPT
Kurshistorie Jährlich EyePoint Pharmaceuticals
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.79 | 24.4 | 2.49 | 12.2 | 6.58 | 15.5 | 18.9 | 10.8 | 17.1 | 48.2 | 41.1 | 39.7 | 12.1 | 11.1 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 48.2 | 2.49 | 19.1 |
Kurshistorie anderer Aktien in der Pharmaeinzelhändler
| Name | Kurshistorie | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M |  Germany |
 |
Arbutus Biopharma Corporation
ABUS
|
2.68 | $ 4.79 | - | $ 795 M |  Canada |
 |
Aclaris Therapeutics
ACRS
|
1.97 | $ 3.04 | - | $ 235 M |  USA |
 |
BioVie
BIVI
|
1.65 | $ 1.27 | - | $ 1.88 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | USA |
 |
Alpine Immune Sciences
ALPN
|
8.04 | - | - | $ 2.17 B | USA |
 |
AlloVir
ALVR
|
9.78 | - | 4.14 % | $ 49.1 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
1.45 | $ 0.18 | - | $ 392 M |  Israel |
 |
Aptorum Group Limited
APM
|
0.75 | $ 1.17 | - | $ 6.38 M |  China |
 |
Ampio Pharmaceuticals
AMPE
|
0.82 | - | -11.43 % | $ 502 K | USA |
 |
Applied Molecular Transport
AMTI
|
0.57 | - | - | $ 10.1 M | USA |
 |
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Celldex Therapeutics
CLDX
|
20.4 | $ 26.83 | - | $ 1.73 M | USA |
 |
Ascendis Pharma A/S
ASND
|
153 | $ 212.81 | - | $ 5 B |  Danmark |
 |
Aptevo Therapeutics
APVO
|
3.22 | $ 0.93 | - | $ 257 K | USA |
 |
Cellectar Biosciences
CLRB
|
3.64 | $ 2.76 | - | $ 33.7 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
0.58 | $ 3.1 | 0.16 % | $ 7.46 B |  Australia |
 |
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M |  France |
 |
Athersys
ATHX
|
0.9 | - | 3.77 % | $ 22.4 M | USA |
 |
Avenue Therapeutics
ATXI
|
0.42 | - | -52.27 % | $ 4.45 M | USA |
 |
CureVac N.V.
CVAC
|
19.3 | $ 4.31 | - | $ 802 M | Germany |
 |
ARCA biopharma
ABIO
|
28.8 | - | 1052.0 % | $ 415 M | USA |
 |
AVROBIO
AVRO
|
1.27 | - | 1083.1 % | $ 745 M | USA |
 |
Acasti Pharma
ACST
|
3.37 | - | 4.01 % | $ 150 M | Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
1.7 | - | -15.15 % | $ 60.3 M | Britain |
 |
BioDelivery Sciences International
BDSI
|
3.1 | - | -4.8 % | $ 255 M | USA |
 |
Albireo Pharma
ALBO
|
28.5 | - | -0.23 % | $ 916 M | USA |
 |
BioNTech SE
BNTX
|
95.4 | $ 95.03 | - | $ 27.2 B | Germany |
 |
Amphastar Pharmaceuticals
AMPH
|
27 | $ 26.81 | - | $ 1.3 B | USA |
 |
BeiGene, Ltd.
BGNE
|
185 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Anika Therapeutics
ANIK
|
25.4 | $ 9.48 | - | $ 139 M | USA |
 |
Bellicum Pharmaceuticals
BLCM
|
0.27 | - | -9.72 % | $ 5.89 M | USA |
 |
Berkeley Lights
BLI
|
1.7 | - | -7.31 % | $ 87 M | USA |
 |
bluebird bio
BLUE
|
0.61 | - | - | $ 546 M | USA |
 |
Dynavax Technologies Corporation
DVAX
|
13.3 | $ 15.38 | - | $ 2 B | USA |
 |
Arena Pharmaceuticals
ARNA
|
92.9 | - | -6.81 % | $ 3.04 B | USA |
 |
Acer Therapeutics
ACER
|
0.77 | - | 2.71 % | $ 14 M | USA |
 |
Calithera Biosciences
CALA
|
13.3 | - | -10.95 % | $ 876 K | USA |
 |
Axon Enterprise
AXON
|
526 | $ 591.15 | - | $ 44.8 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.5 | - | - | $ 7.46 M | Israel |
 |
Eton Pharmaceuticals
ETON
|
4.46 | $ 16.99 | - | $ 436 M | USA |
 |
Aytu BioScience
AYTU
|
2.51 | $ 2.53 | -0.39 % | $ 15.9 M | USA |
 |
AstraZeneca PLC
AZN
|
74.2 | $ 92.45 | - | $ 96.9 B | Britain |
 |
Acorda Therapeutics
ACOR
|
13.5 | - | -24.86 % | $ 820 K | USA |
 |
Catalyst Biosciences
CBIO
|
0.51 | $ 12.37 | 2.06 % | $ 814 M | USA |
 |
Brickell Biotech
BBI
|
2.11 | - | -5.38 % | $ 6.06 M | USA |
|
Foghorn Therapeutics
FHTX
|
4.55 | $ 5.4 | - | $ 296 M | USA |